Clinical Trials Directory

Trials / Unknown

UnknownNCT02450565

Translation of the Self Completed-Leeds Assessment of Neuropathic Symptoms and Signs Pain Scale

Translation and Validation of the Traditional Chinese-Cantonese Version of the Self Completed-Leeds Assessment of Neuropathic Symptoms and Signs Pain Scale

Status
Unknown
Phase
Study type
Observational
Enrollment
200 (estimated)
Sponsor
The University of Hong Kong · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

Neuropathic pain, described as 'pain arising as a direct consequence of a lesion or disease on the somatosensory system', affects up to 3-9.8% of the investigators' population, but is often underdiagnosed and undertreated. As treatment is different for patients with neuropathic pain and nociceptive pain, it is important to screen for neuropathic pain. Commonly employed questionnaire-based diagnostic tools in English speaking countries include the Leeds Assessment of Neuropathic Symptoms and Signs pain scale (LANSS) and Neuropathic pain questionnaire (NPQ). Self-completed LANSS is particularly useful as it is not restricted to clinician's examination and can be applied in large-scale research. S-LANSS has been successfully translated, validated and used successfully in Arabic and Turkish, but it has not been utilised in the Chinese population. As verbal translations of the English questionnaires used at the bedside may be prone to errors in interpretation and requires medical practitioners to interpret the questions. Therefore a translation and validation study is essential.

Conditions

Interventions

TypeNameDescription
OTHERQuestionnaire

Timeline

Start date
2015-07-01
Primary completion
2016-06-01
Completion
2016-06-01
First posted
2015-05-21
Last updated
2015-05-21

Source: ClinicalTrials.gov record NCT02450565. Inclusion in this directory is not an endorsement.